Back to mobile site

United Therapeutics Corp. (UTHR) PT Raised to $175 at Oppenheimer

February 23, 2017 9:27 AM EST Send to a Friend
Oppenheimer raised its price target on United Therapeutics Corp. (NASDAQ: UTHR) to $175.00 (from $160.00) while maintaining a Outperform rating.Analyst ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login